Tesamorelin is a synthetic, 44-amino acid peptide analog of endogenous growth hormone-releasing hormone (GHRH), distinguished by the structural addition of a trans-3-hexenoic acid group at its N-terminus. At the biochemical level, research indicates that this specific modification alters the peptide’s interaction with proteolytic enzymes, shielding the sequence from rapid cleavage and enzymatic degradation. In experimental laboratory models, Tesamorelin is primarily investigated for its binding affinity to the GHRH receptor and its modulation of intracellular cyclic AMP (cAMP) pathways. In vitro research frequently employs Tesamorelin compounds to explore peptide stability, enzyme kinetics, and fundamental biochemical signaling networks in isolated cellular environments.